A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)

Auckland Clinical Studies, Auckland

Alfred Hospital, Melbourne

The Royal Melbourne Hospital - The Walter and Eliza Hall Institute of Medical Research, Parkville

Eastern Health-Box Hill Hospital, Box Hill

The Wesley Hospital - The Wesley Research Institute, Auchenflower

The University of Queensland - Princess Alexandra Hospital, Woolloongabba

Clinical Trials Centre - University of the Sunshine Coast, Sippy Downs

Coral Sea Clinical Research Institute, Mackay

Royal Adelaide Hospital, Adelaide

Sir Charles Gairdner Hospital, Nedlands

P3 Research Limited, Mount Cook

Gastroenterology and Endoscopy Specialists, Christchurch

Celiac Disease Center at Columbia University, New York

Drug Trials America, Hartsdale

Long Island Gastrointestinal Research Group, Great Neck

Thomas Jefferson University Hospitals - Center City Campus, Philadelphia

PMG Research of Winston-Salem, LLC, Winston-Salem

PMG Research of Piedmont Healthcare, Statesville

Coastal Carolina Research, Mt. Pleasant

Alliance Medical Research, Lighthouse PT

Digestive Health Research, Hermitage

Great Lakes Gastroenterology Research, Mentor

Clinical Research Institute of Michigan, Chesterfield

Center for Digestive Health, Troy

West Michigan Clinical Research Center, Wyoming

PMG Research of McFarland Clinic, Ames

University of Iowa, Iowa City

Allegiance Research Specialists, Wauwatosa

Mayo Clinic, Rochester

UCMC - Center for Clinical Cancer Genetics and Global Health, Chicago

Heartland Research Associates, Wichita

Texas Digestive Disease Consultants, Southlake

Grand Teton Research Group, Idaho Falls

Advanced Research Institute, South Ogden

AB Clinical Trials, Las Vegas

Diablo Clinical Research, Walnut Creek

Stamford Therapeutics Consortium, Stamford

ActivMed Practices & Research, Portsmouth

Ocean State Clinical Research Partners, Lincoln

Omega Medical Research, Warwick

P3 Research Limited, Havelock North